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Abstract 
Objective: There is evidence that increasing the proportion of polyunsaturated fatty acids (PUFA) in a diet 
can enhance the rate of fat oxidation acutely. Higher PUFA in a diet has also been associated with greater 
abdominal fat loss in longer term studies. This study aimed to investigate if higher PUFA intake would 
result in greater fat mass loss over a 12-week period, mainly from the abdominal region. 
Methods: Data at the 12-week time point from two weight loss studies, both comparing high PUFA versus 
low PUFA diets was, accessed for 141 overweight subjects from the same area. Specifically, data on 
anthropometric measurements (weight, height, BMI, body composition, waist and hip circumference, SAT, 
VAT) and dietary intake were analyzed. The relationship between fat mass and VAT changes was 
examined using a differential equation. 
Results: Energy consumption decreased significantly in both study groups. The low fat groups decreased 
total dietary fat while the HPUFA groups increased PUFA intake significantly. All anthropometric 
measurements reduced significantly over time but there was no difference between the two dietary 
groups. The relationship between fat mass and visceral adipose tissue (VAT) loss was allometric. 
Conclusion: A higher PUFA intake did not lead to greater fat mass loss and there was no additional 
preferential loss of VAT following higher PUFA consumption. 
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Summary
Objective: There is evidence that increasing the propor-
tion of polyunsaturated fatty acids (PUFA) in a diet can 
enhance the rate of fat oxidation acutely. Higher PUFA 
in a diet has also been associated with greater abdomi-
nal fat loss in longer term studies. This study aimed to 
investigate if higher PUFA intake would result in greater 
fat mass loss over a 12-week period, mainly from the 
abdominal region. Methods: Data at the 12-week time 
point from two weight loss studies, both comparing high 
PUFA versus low PUFA diets was, accessed for 141 over-
weight subjects from the same area. Specifically, data 
on anthropometric measurements (weight, height, BMI, 
body composition, waist and hip circumference, SAT, 
VAT) and dietary intake were analyzed. The relationship 
between fat mass and VAT changes was examined using 
a differential equation. Results: Energy consumption 
decreased significantly in both study groups. The low 
fat groups decreased total dietary fat while the HPUFA 
groups increased PUFA intake significantly. All anthro-
pometric measurements reduced significantly over time 
but there was no difference between the two dietary 
groups. The relationship between fat mass and visceral 
adipose tissue (VAT) loss was allometric. Conclusion: 
A higher PUFA intake did not lead to greater fat mass 
loss and there was no additional preferential loss of VAT 
 following higher PUFA consumption.
Introduction
Dietary fats are high in energy density [1], are the least pre-
ferred source of energy during fuel selection by the body 
[2, 3], and are oxidized inefficiently during overfeeding [4, 5]. 
For these reasons they have been implicated in the etiology of 
the worldwide obesity epidemic. However, fats are crucial in 
maintaining some physiological functions such as maintaining 
cell structure and transportation of fat-soluble vitamins [6]. In 
addition, to fully eliminate fat from the diet is not possible as 
we consume whole foods which come from food sources con-
taining various nutrients in different proportions. Therefore, 
it is advisable to recommend restricting dietary fat intake to a 
sensible level and at the same time include optimal fats within 
a recommended level of intake.
Not all dietary fats have the same physiological functions, 
and there is evidence that different fat subtypes are oxidized 
in a hierarchy in the human body, depending on their chemi-
cal structures. The carbon chain length [7, 8] and degree of 
saturation [7] of fatty acids determine both the rate and order 
in which fats are oxidized. In humans, this order is polyunsat-
urated fatty acids (linolenate 18:3n-3; PUFA) first, followed 
by monounsaturated fatty acids (oleate 18:1n-9; MUFA), and 
saturated fatty acids (stearate 18:0; SFA) last [9]. At a cellular 
level, PUFA has been observed to play a role in repartitioning 
metabolic fuels for storage and oxidation by down-regulating 
the transcription of lipogenic genes and up-regulating the 
genes that promote lipid oxidation and thermogenesis [10]. 
Indeed, in a whole of diet context [11, 12], studies have con-
firmed a greater fat-oxidizing effect acutely when the ratio of 
PUFA:SFA increases. Supplementation of the diet using fish 
oil (PUFA rich) has also been shown to increase fat oxidation 
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body. This differential effect of fat subtypes means that the 
incorporation of PUFA into a diet may be beneficial in the 
promotion of negative fat balance and leads to the use of 
 endogenous fat as energy source. It may be an important con-
sideration in weight management where adipose tissue accu-
mulation is integral to the problem. 
Nonetheless, these observations were obtained from stud-
ies using an acute feeding design, and it remains unclear if an 
enhanced fat oxidation rate can be extended over a longer 
 period of time in a free-living environment. The intriguing 
question is whether or not the increased fat oxidation rate is 
sufficient to induce a state of negative fat balance and cumu-
latively lead to greater fat mass (FM) loss in overweight indi-
viduals. Studies including a higher PUFA intake have been 
associated with a greater FM loss in the abdominal region 
when the intake of PUFA was increased [15, 16]. This is ben-
eficial to overweight individuals as a greater reduction in ab-
dominal FM will lead to improved metabolic fitness and re-
duced risks of metabolic disease [17, 18]. This is particularly 
the case if the loss of FM comes from the visceral adipose tis-
sues (VAT). Hallgreen and Hall [19] analyzed data from 
weight loss trials that employed various methods (calorie re-
striction, exercise, and surgery) and found no preferential loss 
of VAT induced by any of the three methods or their combi-
nations. They concluded that VAT loss is therefore propor-
tionate to the amount of total body FM loss. However, studies 
using high PUFA diets were not included in their analysis. 
Therefore, this study aimed to investigate if a higher PUFA 
intake would result in greater FM loss in the short term, 
mainly from the abdominal region. 
Participants and Methods
Experimental Protocol
Two dietary interventions (Trial A [20] and Trial B [21]) from which data 
was extracted had similar experimental protocols. The key intervention 
for both trials was increased dietary PUFA intake. Trial A was a 12-week 
randomized controlled trial with four study arms while Trial B was a 
52-week randomized controlled trial with two study arms. The study arms 
are summarized in table 1.
Participants from both trials were recruited from the local community 
through media advertisement. Eligible participants attended a pre-study 
assessment session where anthropometric measurements, blood biochemis-
try, habitual dietary intake, and physical activity were assessed. In both 
 trials, participants randomized into the high PUFA arms received struc-
tured dietary advice to incorporate PUFA-rich foods to achieve PUFA tar-
get of 10% energy. The intervention group in Trial B also received a daily 
supplement of 30 g walnuts. All participants received monthly supports 
from qualified dietitians to help adhere to the prescribed diets for the first 
12 weeks. After the 12-week period, participants from Trial B attended 
quarterly follow-up sessions. The experiment protocols from both trials 
were approved by the University of Wollongong Human Research Ethics 
Committee and were registered with the Australian Clinical Trial Registry 
(Trial A: ACTRN12608000453381; Trial B: ACTRN12607000600448)
Participants 
Inclusion criteria for Trial A [20] and Trial B [21] were age > 18 years and 
BMI > 25 kgm-2 (participants of both sexes were included); Trial B also 
included individuals who were diagnosed with type 2 diabetes (without 
insulin treatment). Participants were excluded if they have major illness, 
were smokers, allergic to factors inhibiting the trials, illiterate, or showed 
inadequate conversational English as dietary counseling was the key com-
ponent of the intervention. Eligible participants were randomized into 
one of the study arms using random permuted blocks by a computerized 
random number generator. 20 participants were required in each arm to 
provide a power of 80% in order to detect a change of 20% in VAT, as 
reported by a previous study [15].
Dietary Prescriptions and Physical Activity Recommendations
Dietary recommendations for both Trial A and Trial B were based on 
core food groups to meet the target dietary nutrient composition profile 
of the different test diets. All participants received individualized [20, 21] 
dietary counseling and had the same amount of contact (monthly) with 
qualified dietitians for the first 12 weeks of the studies. Participants in the 
high PUFA (HPUFA) arms were asked to include PUFA-rich foods in 
Trial A while participants in Trial B received a daily supply of walnuts 
(30 g/day) to help achieve PUFA target. Compliance to walnut consump-
tion was confirmed through the significant increase in erythrocyte mem-
brane -linoleic acid in the HPUFA group from baseline to 12 weeks [21]. 
Participants were also advised to maintain 5 × 30-min physical activity per 
week. 
Table 1. Study arms of Trial A and Trial B studies
Trial A
Low PUFA High PUFA Low PUFA and  low energy High PUFA & low energy
Isocaloric low-fat diet with 20% 
protein, 50% CHO, 30% fat (5% 
PUFA, 15% MUFA, 10% SFA).
Isocaloric low-fat high PUFA 
diet with 20% protein, 50% 
CHO, 30% fat (10% PUFA, 
10% MUFA, 10% SFA).
A diet similar to the low fat diet 
but with a 500 kcal/d energy 
deficit.
A diet similar to the high PUFA 
diet but with a 500 kcal/d energy 
deficit.
Trial B
Low PUFA High PUFA
Isocaloric low-fat diet with 20% protein, 50% CHO, 30% fat  
(5% PUFA, 15% MUFA, 10%SFA). This study arm is the equivalent  
of the low fat arm in Trial A.
Isocaloric low-fat high PUFA diet with 20% protein, 50% CHO,  
30% fat (10% PUFA, 10% MUFA, 10% SFA). This study arm is the  
equivalent of the high PUFA arm in Trial A.
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Dietary Intake
Habitual dietary intake was assessed using a validated diet history inter-
view [25] conducted by dietitians and a 3-day food record. Dietary com-
position was analyzed using the FoodWorks nutrient analysis software 
package (Xyris Software, Professional Version 2002, Brisbane, Aus-
tralia). Fatty acid intake profiles were obtained using the AUSNUT 
fatty acid database (Version 6, 2002) in the FoodWorks  software pack-
age and the Australian Fatty Acids Rev 6 2002 (RMIT, Melbourne, 
Australia).
Data Analysis
For the purpose of this paper, only data collected at baseline and 12 
weeks was included. Data from Trial A and Trial B were combined in 
order to test the relationship between FM and VAT changes. The study 
arms in both studies were collapsed into low fat (LPUFA) and HPUFA 
groups for comparison purposes. Data was analyzed using SPSS statistical 
software (version 15.0.0, SPSS, Chicago, IL, USA). Baseline differences 
between diet groups were assessed using one-way ANOVA, with post 
hoc comparisons using a Bonferroni adjustment. Changes in the primary 
outcomes between LPUFA and HPUFA were compared using the 
 general linear model for repeated measures ANOVA.
Results
Participants
From both Trial A and Trial B, 273 participants were 
screened, where 200 were eligible and enrolled. They were 
randomly assigned to one of the study arms. 28 volunteers 
withdrew prior to the commencement of the studies (Trial A, 
n = 18; Trial B, n = 10), and 31 were lost to follow-up visits 
(Trial A, n = 11; Trial B, n = 20). Of the original 200 partici-
pants, 141 completed the studies. Data from 121 out of the 
Measurements 
Body Weight and Body Composition
Body weight was measured, and percentage body fat was estimated using 
scales with bioelectrical impedance (Tanita TBF622; Tanita Corp., 
Tokyo, Japan) in an upright position with minimal clothing. Body fat 
measurements from this device have been previously shown to be compa-
rable to those from the DEXA scans [22]. Single-slice abdominal com-
puted tomography (CT) scans were also taken at the fourth and fifth 
 lumbar vertebra (L4–L5), as well as at the level of sacroiliac joints by a 
trained observer at a commercial X-ray facility in Wollongong (South-
coast X-Ray, NSW, Australia). Subcutaneous adipose tissue (SAT) and 
VAT areas at L4–L5 levels were estimated using SIENET Sky software 
(Siemens AG, Munich, Germany), and the mean of these two levels were 
calculated. Using the mean VAT areas (AVAT), total volume of VAT 
(VVAT) at the abdominal region was estimated using the equations 
 described by Shen and colleagues [23]: 
Men: VVAT = 0.0224 × AVAT + 0.162 l  (1)
Women: VVAT = 0.0205 × AVAT + 0.147 l  (2)
Relationship between FM and VAT Loss
To examine if there is preferential loss of VAT, its changes will be exam-
ined alongside total FM loss using the mathematical model described by 
Hallgreen and Hall [19], which was an extension to the observations by 
the original works by Smith and Zachwieja [24]. It was hypothesized that 
FM and VAT changes follow an allometric relationship as shown by the 
differential equation below:
VAT/FM = k × dVAT/dFM (3)
where VAT and FM refer to initial (before treatment) VAT and FM; 
dVAT and dFM refer to changes in VAT and FM over time; and k is the 
dimensionless constant which can be calculated from the other 4 known 
variables.
Table 2. Mean (± SD) anthropometric measurements and dietary intakes at baseline and after 12 weeks
























































































































LPUFA = Low PUFA group; HPUFA = high PUFA group ; VAT = visceral adipose tissue; SAT = subcutaneous adipose tissue; EI = energy intake; 
CHO = carbohydrate; PUFA = polyunsaturated fat; MUFA = monounsaturated fat; SFA = saturated fat.
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complete data sets containing FM and VAT volume from 
Trial A and Trial B were analyzed. Baseline and post-inter-
vention (12-week) measurements of weight, BMI, FM, fat-
free mass (FFM), and VAT volume are presented in table 3. 
FM and volume of VAT decreased significantly in both 
groups after the 12-week period, but there was no differ-
ence between LPUFA and HPUFA groups. The dimen-
sionless constant was k = 1.15 ± 3.59 for the LPUFA group 
and k = 1.23 ± 2.86 for the HPUFA group, and they were 
not significantly different between groups (independent 
sample t-test, p = 0.896).
Discussion
This study aimed to investigate the relationship between die-
tary PUFA intake, FM loss as well as preferential abdominal 
FM loss as reported by other studies. Using the data from two 
intervention trials, we showed that the enhanced fat oxidation 
by PUFA observed in acute studies failed to produce greater 
FM loss using a longitudinal study design. Previous studies 
 reported abdominal fat loss and total FM loss independently; 
when we examined them together, preferential loss of abdom-
inal fat following increased PUFA intake was not observed.
There were some limitations to this study. It included con-
venient samples obtained from two separate clinical trials that 
utilized different dietary strategies. However, the treatments 
and study protocols were similar (high vs. low PUFA intake), 
and the clinical outcomes were not likely to be confounded by 
these differences. This study compared data between baseline 
and 12 weeks only, making the comparison over a longer pe-
riod of time impossible. This was due to the length of original 
study (Trial A), but 3-month changes in weight and body 
composition are still of clinical importance. There was also 
concern over the PUFA consumptions in both study groups, 
where some participants in LPUFA group consumed higher 
141 subjects was included because CT scans at both time 
points were available. 20 subjects did not have the CT scan 
done at 12 weeks of the studies, and data from these subjects 
were excluded. Baseline characteristics and habitual intake of 
these participants were not statistically different (p > 0.05) 
(table 2).
Dietary Change
Dietary intervention effect was achieved in Trial A and Trial 
B. The combined analysis for the purpose of this paper shows 
that the intakes of energy and macronutrients changed signi-
ficantly within each study group (table 2) after the 12-week 
intervention period. Of all macronutrients, only the percent-
ages of total fat (diet, p = 0.018) and PUFA (diet, p < 0.001) 
were significantly different between groups, where the 
LPUFA group reduced fat intake and the HPUFA group in-
creased PUFA consumption. The interaction effects were sig-
nificant for carbohydrate (p = 0.035), SFA (p = 0.003) and 
PUFA (p < 0.001) proportions in the diets. The LPUFA 
group increased the proportion of carbohydrate to substitute 
dietary fat while the HPUFA group increased their PUFA 
 intake at the expense of SFA in the diet.
Anthropometric Change
Weight change was significant in the original studies (Trial A 
and Trial B), and when data was combined and analyzed in 
this study, all groups also lost weight significantly after the 
12-week period. Subsequently, all other parameters were 
 significantly reduced over time (time, p ≤ 0.001). However, 
these changes were not different between the LPUFA and 
HPUFA groups, and interaction effects were also not ob-
served (table 2).
Relationship between FM and VAT Changes
To test if the relationship between the changes of these two 
variables was allometric, 121 (58 LPUFA and 63 HPUFA) 
Table 3. Characteristics of participants (N = 121) at baseline and 12-week of study
































































LPUFA = Low PUFA group; HPUFA = high PUFA group; FM = fat mass; FFM = fat-free mass; VAT = visceral adipose tissue.
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in a free-living environment. These are the areas that warrant 
further investigation.
Changes in FM in our analysis follow a similar trend to 
weight loss with a significant FM loss over time, but no diet 
effect was observed. Although there is indication that higher 
PUFA consumption acutely enhanced fat oxidation [9], our 
data suggests that this acute effect could not be translated 
into weight loss in the longer term in a free-living environ-
ment. Our observation is not consistent with the results of a 
study by Couet and colleagues [14] who found significantly 
greater FM loss over a 3-week period. This may be due to the 
differences in a few aspects of the study. Overweight parti-
cipants in our study may have different fat oxidation rates to 
the lean subjects in study by Couet et al. [28], where over-
weight individuals have been shown to have blunted lipid 
 oxidation. The difference in the length of study and the use of 
supplements and how they are digested and metabolized may 
impact on the compliance to the treatment. At this stage, the 
effects of adaptations of the human body to increased dietary 
PUFA  remains unclear.There was a significant interaction 
 effect of treatment on FFM changes in our study, where 
the HPUFA group lost more FFM than the LPUFA group 
(–0.3 kg/12 weeks vs. –0.9 kg/12 weeks). The significant 
change in FFM was a novel observation because limited stud-
ies have compared the effectiveness of high versus low PUFA 
diets in promoting weight and FM loss. From a mechanistic 
perspective, it may be speculated that higher PUFA intake 
increases skeletal muscle membrane PUFA composition, 
which has been reported to be inversely correlated with fast-
ing insulin level [29]. Indeed, a significantly greater decrease 
in fasting insulin in the HPUFA group was observed in Trial 
B [21]. Insulin is an anabolic hormone, and its decrease re-
lated to increased PUFA intake may have contributed to the 
greater FFM loss in the HPUFA arm in this study. Further 
investigations are required to explain such observation since 
empirical data to support this speculation is lacking. 
The current analysis did not demonstrate additional bene-
fits of a HPUFA diet on abdominal fat loss. This was evident 
from the similar changes in SAT and VAT areas in both 
study groups. When VAT area was converted into VAT vol-
ume, changes in VAT were again not significantly different 
between groups. The mean k values, calculated using equa-
tion (3), as outlined in the methods section, were very close 
to those reported by Hallgreen and Hall [19], where studies 
using energy restriction alone produced a mean value of 
k = 1.2 while combined strategies involving energy restriction 
and resistance exercise produced k = 1.3. Effects of LPUFA 
diet in this study generated a k value close to energy re-
striction (mean k = 1.15), while k of HPUFA fell between 
 energy restriction with and without resistance exercise (mean 
k = 1.23). Nonetheless, dimensionless constant k was not dif-
ferent between LPUFA and HPUFA groups, implying that 
there is preferential loss of VAT (k > 1), but it was not differ-
ent from VAT loss induced by other weight loss strategies.
PUFA while some in the HPUFA group consumed low 
PUFA during the data collection period. When we performed 
head-to-head comparison, the change in PUFA intake and 
FM (0–12 weeks) did not correlate for all participants (r = 
0.076, p = 0.409). It turns out that this analysis further sup-
ports and strengthens our observation that changing PUFA 
intake may have limited impact on body FM. Physical activity 
was not measured during the intervention period, and it was 
uncertain if this has changed. Precautions were taken in the 
original  trials where participants were told to maintain 30-min 
exercise five times a week, and this was emphasized by the 
die titians on a monthly basis. 
This study also has a number of strengths. First, it exam-
ines the possibilities of acute metabolic effects of increased 
PUFA intake observed in a controlled laboratory setting be 
extended into a less-restrictive free-living environment over a 
12-week period. This is crucial in demonstrating the effective-
ness and practicality of a weight management strategy. An-
other strength of this study is that it differs from the previous 
studies in that it compares the change in visceral fat relative to 
the total fat change, not in isolation. Pooling data from our 
two previous studies that originally addressed other specific 
study outcomes provided us with a greater sample size to ex-
amine this issue. This study points out errors in conclusions 
that can be drawn if FM and VAT are considered independ-
ently. For example, although the between-groups differences 
in VAT area and volume were approaching statistical signifi-
cance (p = 0.052 and p = 0.065, respectively), they diminished 
(p = 0.896) when examined as a ratio to total FM change. 
The failure to replicate the results from previous studies 
was not likely to be confounded by the dietary compliance in 
this study, where dietary effects were reported in the original 
trials, and the combined data. Diet history analyses showed 
that the HPUFA groups increased their PUFA proportion in 
the diet while the LPUFA groups did not change their PUFA 
consumption after 12 weeks, indicating effective and success-
ful execution of dietary interventions. One can increase the 
intake of PUFA by substituting SFA either through careful 
dietary modeling to identify and incorporate PUFA-rich 
foods into the diet or by supplementing with foods like 
walnuts.
This study was motivated by previous research that re-
ported a higher thermogenic effect of PUFA in the short 
term, where the basal metabolic rate and thermic effect of 
food were observed to elevate following meals with higher 
PUFA content [26, 27]. However, this was not reflected in our 
study as the weight loss of participants in the HPUFA group 
was not higher than that in the LPUFA group, although both 
groups lost weight significantly over the 12-week study pe-
riod. Weight loss is likely to largely result from the signifi-
cantly lower energy intake after 12 weeks as shown in table 2. 
This implies that either the elevated thermogenesis was not 
great enough to produce a significantly greater weight loss or 
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Conclusion
Energy restriction produced greater weight loss with or with-
out increasing PUFA in the diet. The HPUFA diet failed to 
produce greater FM loss despite greater fat oxidation rates 
observed in other acute feeding trials. The dimensionless con-
stant, k, was also not different, implying that there was no 
preferential fat oxidation in the abdominal region from the 
higher PUFA intake. This study suggests that the loss of VAT 
depends on the total loss of body FM and is minimally in-
fluenced by the PUFA in the diet. 
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